ERBB2 and aneurysmal bone cyst: Although the incidence of CNS metastases in HR+/HER2− ABC is much lower than that in either HER2‐positive or triple‐negative ABC, it still ranges from 8.3% to 15%, with a median OS of 14 (4–34) months [12, 13, 14, 15, 16, 17].